Combination Strategies and Targeted Radionuclide Therapies
- Author(s)
- Jewell, K; Kostos, L; Emmerson, B; Hofman, MS;
- Details
- Publication Year 2024-07,Volume 54,Issue #4,Page 612-621
- Journal Title
- Seminars in Nuclear Medicine
- Publication Type
- Review
- Abstract
- Combination models utilising treatments from two or more therapeutic classes are well established in cancer care. In the new era of theranostic (theragnostic) medicine there is an ongoing need to identify and refine novel combination strategies to optimise multidisciplinary care for conditions commonly encountered in nuclear medicine such as neuroendocrine neoplasms (NEN), prostate cancer (PCa), and thyroid cancer, along with seeking advancements in molecular imaging and therapy techniques for other tumour streams. This concise review explores the background of theranostic monotherapy, established approaches to combination strategies in theranostics, and emerging targeted radionuclide therapies in use or under active investigation, with a focus on Australian-led studies.
- Publisher
- Elsevier
- Keywords
- Humans; *Radioisotopes/therapeutic use; Combined Modality Therapy; Neoplasms/radiotherapy/diagnostic imaging
- Department(s)
- Cancer Imaging; Medical Oncology
- Publisher's Version
- https://doi.org/10.1053/j.semnuclmed.2024.05.011
- Open Access at Publisher's Site
https://doi.org/10.1053/j.semnuclmed.2024.05.011- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-29 04:21:46
Last Modified: 2024-08-29 04:22:02